APA (7th ed.) Citation

A, P., A, S., B, H., I, M., M, Z., XD, N., . . . S, U. (2009). Differential clinical significance of individual NKG2D ligands in melanoma: Soluble ULBP2 as an indicator of poor prognosis superior to S100B. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(16), 5208. https://doi.org/10.1158/1078-0432.CCR-09-0886

Chicago Style (17th ed.) Citation

A, Paschen, et al. "Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15, no. 16 (2009): 5208. https://doi.org/10.1158/1078-0432.CCR-09-0886.

MLA (9th ed.) Citation

A, Paschen, et al. "Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 15, no. 16, 2009, p. 5208, https://doi.org/10.1158/1078-0432.CCR-09-0886.